OBJECTIVES: The severity of acute carbon monoxide (CO) poisoning is often based on non-specific clinical criteria because there are no reliable laboratory markers. We hypothesized that a pattern of plasma protein values might objectively discern CO poisoning severity. This was a pilot study to evaluate protein profiles in plasma samples collected from patients at the time of initial hospital evaluation. The goal was to assess whether any values differed from age- and sex-matched controls using a commercially available plasma screening package. METHODS: Frozen samples from 63 suspected CO poisoning patients categorized based on clinical signs, symptoms, and blood carboxyhemoglobin level were analyzed along with 42 age- and sex-matched controls using Luminex-based technology to determine the concentration of 180 proteins. RESULTS: Significant differences from control values were found for 99 proteins in at least one of five CO poisoning groups. A complex pattern of elevations in acute phase reactants and proteins associated with inflammatory responses including chemokines/cytokines and interleukins, growth factors, hormones, and an array of auto-antibodies was found. Fourteen protein values were significantly different from control in all CO groups, including patients with nominal carboxyhemoglobin elevations and relatively brief intervals of exposure. CONCLUSIONS: The data demonstrate the complexity of CO pathophysiology and support a view that exposure causes acute inflammatory events in humans. This pilot study has insufficient power to discern reliable differences among patients who develop neurological sequelae but future trials are warranted to determine whether plasma profiles predict mortality and morbidity risks of CO poisoning.
OBJECTIVES: The severity of acute carbon monoxide (CO) poisoning is often based on non-specific clinical criteria because there are no reliable laboratory markers. We hypothesized that a pattern of plasma protein values might objectively discern CO poisoning severity. This was a pilot study to evaluate protein profiles in plasma samples collected from patients at the time of initial hospital evaluation. The goal was to assess whether any values differed from age- and sex-matched controls using a commercially available plasma screening package. METHODS: Frozen samples from 63 suspected CO poisoningpatients categorized based on clinical signs, symptoms, and blood carboxyhemoglobin level were analyzed along with 42 age- and sex-matched controls using Luminex-based technology to determine the concentration of 180 proteins. RESULTS: Significant differences from control values were found for 99 proteins in at least one of five CO poisoning groups. A complex pattern of elevations in acute phase reactants and proteins associated with inflammatory responses including chemokines/cytokines and interleukins, growth factors, hormones, and an array of auto-antibodies was found. Fourteen protein values were significantly different from control in all CO groups, including patients with nominal carboxyhemoglobin elevations and relatively brief intervals of exposure. CONCLUSIONS: The data demonstrate the complexity of CO pathophysiology and support a view that exposure causes acute inflammatory events in humans. This pilot study has insufficient power to discern reliable differences among patients who develop neurological sequelae but future trials are warranted to determine whether plasma profiles predict mortality and morbidity risks of CO poisoning.
Authors: Miguel P Soares; Mark P Seldon; Isabel Pombo Gregoire; Tatiana Vassilevskaia; Pascal O Berberat; Jia Yu; Tung-Yu Tsui; Fritz H Bach Journal: J Immunol Date: 2004-03-15 Impact factor: 5.422
Authors: Stephen R Thom; Veena M Bhopale; Donald Fisher; Jie Zhang; Phyllis Gimotty Journal: Proc Natl Acad Sci U S A Date: 2004-09-01 Impact factor: 11.205
Authors: Martin Bilban; Arvand Haschemi; Barbara Wegiel; Beek Y Chin; Oswald Wagner; Leo E Otterbein Journal: J Mol Med (Berl) Date: 2007-11-22 Impact factor: 4.599
Authors: Brian S Zuckerbraun; Timothy R Billiar; Sherrie L Otterbein; Peter K M Kim; Fang Liu; Augustine M K Choi; Fritz H Bach; Leo E Otterbein Journal: J Exp Med Date: 2003-12-01 Impact factor: 14.307
Authors: Regina Rückerl; Sonja Greven; Petter Ljungman; Pasi Aalto; Charalambos Antoniades; Tom Bellander; Niklas Berglind; Christina Chrysohoou; Francesco Forastiere; Bénédicte Jacquemin; Stephanie von Klot; Wolfgang Koenig; Helmut Küchenhoff; Timo Lanki; Juha Pekkanen; Carlo A Perucci; Alexandra Schneider; Jordi Sunyer; Annette Peters Journal: Environ Health Perspect Date: 2007-07 Impact factor: 9.031
Authors: Luca Martani; Andrea Giovanniello; Gerardo Bosco; Luca Cantadori; Francesca Calissi; Dany Furfaro; Massimo Pedrazzini; Rosanna Vaschetto; Enrico Mario Camporesi; Matteo Paganini Journal: Int J Environ Res Public Health Date: 2022-04-27 Impact factor: 4.614
Authors: Jiajun Xu; Ming Yang; Paul Kosterin; Brian M Salzberg; Tatyana N Milovanova; Veena M Bhopale; Stephen R Thom Journal: Toxicol Appl Pharmacol Date: 2013-09-30 Impact factor: 4.219